vs

Side-by-side financial comparison of CHIMERA INVESTMENT CORP (CIM) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.

VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $66.2M, roughly 1.2× CHIMERA INVESTMENT CORP). CHIMERA INVESTMENT CORP runs the higher net margin — 42.8% vs 7.4%, a 35.4% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs 0.5%). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs 0.8%).

Chimera Investment Corp is a US-based real estate investment trust (REIT) primarily investing in residential mortgage-backed securities, residential and commercial mortgage loans, and other real estate-related financial assets. It delivers sustainable risk-adjusted returns for shareholders via regular dividend distributions from its investment portfolio.

Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.

CIM vs VMD — Head-to-Head

Bigger by revenue
VMD
VMD
1.2× larger
VMD
$76.2M
$66.2M
CIM
Growing faster (revenue YoY)
VMD
VMD
+25.0% gap
VMD
25.5%
0.5%
CIM
Higher net margin
CIM
CIM
35.4% more per $
CIM
42.8%
7.4%
VMD
Faster 2-yr revenue CAGR
VMD
VMD
Annualised
VMD
22.7%
0.8%
CIM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CIM
CIM
VMD
VMD
Revenue
$66.2M
$76.2M
Net Profit
$28.3M
$5.6M
Gross Margin
57.9%
Operating Margin
42.6%
11.0%
Net Margin
42.8%
7.4%
Revenue YoY
0.5%
25.5%
Net Profit YoY
119.3%
30.7%
EPS (diluted)
$0.05
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CIM
CIM
VMD
VMD
Q4 25
$66.2M
$76.2M
Q3 25
$65.0M
$71.9M
Q2 25
$66.0M
$63.1M
Q1 25
$69.2M
$59.1M
Q4 24
$65.8M
$60.7M
Q3 24
$66.5M
$58.0M
Q2 24
$67.3M
$55.0M
Q1 24
$65.1M
$50.6M
Net Profit
CIM
CIM
VMD
VMD
Q4 25
$28.3M
$5.6M
Q3 25
$-580.0K
$3.5M
Q2 25
$35.5M
$3.2M
Q1 25
$167.3M
$2.6M
Q4 24
$-146.5M
$4.3M
Q3 24
$136.5M
$3.9M
Q2 24
$56.7M
$1.5M
Q1 24
$129.5M
$1.6M
Gross Margin
CIM
CIM
VMD
VMD
Q4 25
57.9%
Q3 25
57.5%
Q2 25
58.3%
Q1 25
56.3%
Q4 24
59.5%
Q3 24
59.3%
Q2 24
59.8%
Q1 24
58.9%
Operating Margin
CIM
CIM
VMD
VMD
Q4 25
42.6%
11.0%
Q3 25
-0.5%
7.8%
Q2 25
54.3%
8.1%
Q1 25
6.5%
Q4 24
-222.6%
10.6%
Q3 24
9.7%
Q2 24
84.2%
6.6%
Q1 24
4.4%
Net Margin
CIM
CIM
VMD
VMD
Q4 25
42.8%
7.4%
Q3 25
-0.9%
4.9%
Q2 25
53.7%
5.0%
Q1 25
241.7%
4.4%
Q4 24
-222.6%
7.1%
Q3 24
205.4%
6.7%
Q2 24
84.2%
2.7%
Q1 24
198.8%
3.2%
EPS (diluted)
CIM
CIM
VMD
VMD
Q4 25
$0.05
$0.14
Q3 25
$-0.27
$0.09
Q2 25
$0.17
$0.08
Q1 25
$1.77
$0.06
Q4 24
$-2.06
$0.10
Q3 24
$1.39
$0.10
Q2 24
$0.41
$0.04
Q1 24
$1.36
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CIM
CIM
VMD
VMD
Cash + ST InvestmentsLiquidity on hand
$278.6M
$13.5M
Total DebtLower is stronger
$251.5M
Stockholders' EquityBook value
$2.6B
$141.5M
Total Assets
$15.8B
$199.2M
Debt / EquityLower = less leverage
0.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CIM
CIM
VMD
VMD
Q4 25
$278.6M
$13.5M
Q3 25
$491.5M
$11.1M
Q2 25
$250.2M
$20.0M
Q1 25
$253.3M
$10.2M
Q4 24
$84.0M
$17.5M
Q3 24
$97.3M
$11.3M
Q2 24
$162.3M
$8.8M
Q1 24
$169.0M
$7.3M
Total Debt
CIM
CIM
VMD
VMD
Q4 25
$251.5M
Q3 25
$251.0M
Q2 25
$135.2M
Q1 25
$134.9M
Q4 24
$134.6M
Q3 24
$134.4M
Q2 24
$62.4M
Q1 24
Stockholders' Equity
CIM
CIM
VMD
VMD
Q4 25
$2.6B
$141.5M
Q3 25
$2.6B
$133.6M
Q2 25
$2.6B
$139.7M
Q1 25
$2.6B
$134.8M
Q4 24
$2.5B
$131.4M
Q3 24
$2.7B
$125.0M
Q2 24
$2.6B
$119.4M
Q1 24
$2.6B
$116.3M
Total Assets
CIM
CIM
VMD
VMD
Q4 25
$15.8B
$199.2M
Q3 25
$15.1B
$202.4M
Q2 25
$14.9B
$184.6M
Q1 25
$13.2B
$178.1M
Q4 24
$13.1B
$177.1M
Q3 24
$13.7B
$169.5M
Q2 24
$13.1B
$163.9M
Q1 24
$12.5B
$154.9M
Debt / Equity
CIM
CIM
VMD
VMD
Q4 25
0.10×
Q3 25
0.10×
Q2 25
0.05×
Q1 25
0.05×
Q4 24
0.05×
Q3 24
0.05×
Q2 24
0.02×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CIM
CIM
VMD
VMD
Operating Cash FlowLast quarter
$-248.9M
$18.4M
Free Cash FlowOCF − Capex
$9.7M
FCF MarginFCF / Revenue
12.7%
Capex IntensityCapex / Revenue
11.5%
Cash ConversionOCF / Net Profit
-8.78×
3.27×
TTM Free Cash FlowTrailing 4 quarters
$11.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CIM
CIM
VMD
VMD
Q4 25
$-248.9M
$18.4M
Q3 25
$-137.5M
$18.4M
Q2 25
$-7.4M
$12.3M
Q1 25
$48.8M
$2.9M
Q4 24
$205.7M
$15.0M
Q3 24
$41.4M
$12.7M
Q2 24
$69.0M
$10.2M
Q1 24
$57.3M
$1.2M
Free Cash Flow
CIM
CIM
VMD
VMD
Q4 25
$9.7M
Q3 25
$10.7M
Q2 25
$4.1M
Q1 25
$-12.6M
Q4 24
$3.2M
Q3 24
$1.7M
Q2 24
$1.2M
Q1 24
$-4.8M
FCF Margin
CIM
CIM
VMD
VMD
Q4 25
12.7%
Q3 25
14.9%
Q2 25
6.5%
Q1 25
-21.4%
Q4 24
5.2%
Q3 24
3.0%
Q2 24
2.3%
Q1 24
-9.5%
Capex Intensity
CIM
CIM
VMD
VMD
Q4 25
11.5%
Q3 25
10.6%
Q2 25
12.9%
Q1 25
26.2%
Q4 24
19.5%
Q3 24
19.0%
Q2 24
16.3%
Q1 24
11.9%
Cash Conversion
CIM
CIM
VMD
VMD
Q4 25
-8.78×
3.27×
Q3 25
5.23×
Q2 25
-0.21×
3.88×
Q1 25
0.29×
1.09×
Q4 24
3.47×
Q3 24
0.30×
3.29×
Q2 24
1.22×
6.94×
Q1 24
0.44×
0.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons